Skip links

PRESS RELEASE: MBH acted as Egyptian counsel to Acino in the acquisition of prescription and OTC products from Takeda Pharmaceuticals

Matouk Bassiouny & Hennawy (“MBH”) acted as Egyptian counsel to Acino, a Swiss pharmaceutical company, with Latham & Watkins as international counsel, in the acquisition of selected prescription and over-the-counter assets from Takeda pharmaceuticals, a multinational pharmaceutical company headquartered in Japan. The deal is valued at an excess of USD 200 million and closing was announced on 2 March 2020.

The MBH team assisting on the transaction was led by Omar S. Bassiouny (Founding Partner and Head of Corporate and M&A) and Muhammad Nassef (Partner), and included Khalid Al-Melegi (Associate) and Lina Raouf (Junior Associate).

 

For further press related inquiries please contact Mary Harding (mary.harding@matoukbassiouny.com).